668 | Humans |
390 | Female |
321 | Male |
246 | Middle Aged |
200 | Adult |
192 | Aged |
105 | Treatment Outcome |
98 | Adolescent |
94 | Animals |
90 | Polymorphism, Single Nucleotide |
89 | Genetic Predisposition to Disease |
85 | Young Adult |
79 | Risk Factors |
72 | Genome-Wide Association Study |
69 | Child |
64 | Aged, 80 and over |
60 | Breast Neoplasms |
59 | Case-Control Studies |
52 | Genotype |
51 | Prognosis |
49 | Time Factors |
43 | Mutation |
43 | Child, Preschool |
38 | Double-Blind Method |
37 | Practice Guidelines as Topic |
35 | Infant |
34 | Follow-Up Studies |
34 | Europe |
34 | Disease-Free Survival |
34 | Age Factors |
33 | Antineoplastic Combined Chemotherapy Protocols |
32 | Retrospective Studies |
32 | Phenotype |
32 | Cohort Studies |
31 | Global Health |
31 | European Continental Ancestry Group |
29 | Risk |
29 | Prospective Studies |
28 | Survival Rate |
28 | Ovarian Neoplasms |
28 | Genetic Variation |
27 | Severity of Illness Index |
27 | Neoplasms |
26 | Neoplasm Staging |
25 | Risk Assessment |
25 | Evidence-Based Medicine |
24 | Reproducibility of Results |
24 | Mice |
24 | International Cooperation |
24 | Disease Progression |
24 | Antineoplastic Agents |
22 | Surveys and Questionnaires |
22 | Proportional Hazards Models |
22 | Odds Ratio |
22 | Genetic Association Studies |
21 | Genetic Loci |
21 | Drug Therapy, Combination |
21 | Consensus |
21 | Alleles |
20 | Signal Transduction |
20 | Quality of Life |
20 | Kaplan-Meier Estimate |
20 | Clinical Trials as Topic |
19 | Registries |
19 | Randomized Controlled Trials as Topic |
19 | Quantitative Trait Loci |
19 | Magnetic Resonance Imaging |
19 | Incidence |
19 | Chromosome Mapping |
18 | Phylogeny |
18 | Internationality |
18 | Brain |
17 | Sequence Analysis, DNA |
17 | Recurrence |
17 | Neoplasm Recurrence, Local |
17 | Infant, Newborn |
17 | Genome, Human |
17 | Drug Administration Schedule |
17 | Computational Biology |
16 | Research Design |
16 | Biodiversity |
16 | Australia |
15 | Societies, Medical |
15 | Molecular Sequence Data |
15 | Genomics |
15 | Disease Management |
15 | Body Mass Index |
14 | Stroke |
14 | High-Throughput Nucleotide Sequencing |
14 | Cross-Sectional Studies |
14 | Algorithms |
13 | Survival Analysis |
13 | Prostatic Neoplasms |
13 | Melanoma |
13 | Hematopoietic Stem Cell Transplantation |
13 | Guidelines as Topic |
13 | Gene Expression Profiling |
13 | Exome |
13 | Evolution, Molecular |
13 | Canada |
13 | Antibodies, Monoclonal, Humanized |
12 | Prevalence |
12 | Outcome Assessment (Health Care) |
12 | Mutation, Missense |
12 | Multivariate Analysis |
12 | Imidazoles |
12 | Gene Frequency |
12 | Ecosystem |
12 | Conservation of Natural Resources |
12 | Antiviral Agents |
12 | Antibodies, Monoclonal |
12 | Age of Onset |
11 | Tumor Suppressor Proteins |
11 | Software |
11 | Sex Factors |
11 | Pregnancy |
11 | Neuropsychological Tests |
11 | Neoplasm Grading |
11 | Hospital Mortality |
11 | Haplotypes |
11 | Genetic Testing |
11 | Databases, Genetic |
11 | Databases, Factual |
11 | DNA Mutational Analysis |
11 | Biomarkers |
10 | Skin Neoplasms |
10 | Promoter Regions, Genetic |
10 | Pedigree |
10 | Meta-Analysis as Topic |
10 | Lung Neoplasms |
10 | Heterozygote |
10 | Germ-Line Mutation |
10 | Dose-Response Relationship, Drug |
10 | Cognition Disorders |
10 | BRCA1 Protein |
10 | Amino Acid Sequence |
10 | Aging |
9 | Viral Load |
9 | United States |
9 | Species Specificity |
9 | Respiration, Artificial |
9 | Remission Induction |
9 | Recombinant Proteins |
9 | Protein Kinase Inhibitors |
9 | Polyethylene Glycols |
9 | Paclitaxel |
9 | Myocardial Infarction |
9 | Logistic Models |
9 | Injections, Subcutaneous |
9 | Immunosuppressive Agents |
9 | Hospitalization |
9 | Electrocardiography |
9 | Diabetes Mellitus, Type 2 |
9 | Colorectal Neoplasms |
9 | Cell Line, Tumor |
9 | Cardiovascular Diseases |
9 | Brain Neoplasms |
9 | Brain Ischemia |
9 | Bipolar Disorder |
9 | Biomarkers, Tumor |
9 | Adenocarcinoma |
8 | Transplantation Conditioning |
8 | Terminology as Topic |
8 | Respiratory Distress Syndrome, Adult |
8 | Receptor, ErbB-2 |
8 | Predictive Value of Tests |
8 | Percutaneous Coronary Intervention |
8 | Obesity |
8 | Nuclear Proteins |
8 | Models, Biological |
8 | Membrane Proteins |
8 | Longitudinal Studies |
8 | Kidney Neoplasms |
8 | Information Dissemination |
8 | Hepatitis C, Chronic |
8 | Genes, BRCA2 |
8 | Gene Expression Regulation |
8 | Disease Models, Animal |
8 | DNA-Binding Proteins |
8 | DNA Copy Number Variations |
8 | Combined Modality Therapy |
8 | Carrier Proteins |
8 | Blood Pressure |
8 | Biological Evolution |
8 | Base Sequence |
8 | Asthma |
8 | Arthritis, Rheumatoid |
7 | United Kingdom |
7 | Smoking |
7 | Sex Distribution |
7 | Sensitivity and Specificity |
7 | Rheumatology |
7 | Receptors, Estrogen |
7 | RNA, Messenger |
7 | Pyrimidines |
7 | Nerve Tissue Proteins |
7 | Neoplasm Metastasis |
7 | Multiple Myeloma |
7 | Models, Statistical |
7 | Mice, Inbred C57BL |
7 | Intensive Care Units |
7 | Immunohistochemistry |
7 | HIV Infections |
7 | Glioma |
7 | Genes, BRCA1 |
7 | Gene Expression Regulation, Neoplastic |
7 | Extinction, Biological |
7 | Comorbidity |
7 | Cause of Death |
7 | Carcinoma, Renal Cell |
7 | Bone Neoplasms |
7 | Blood Glucose |
7 | Biomedical Research |
7 | Asian Continental Ancestry Group |
7 | Alzheimer Disease |
7 | Age Distribution |
7 | Acute Coronary Syndrome |
6 | Trees |
6 | Transplantation, Homologous |
6 | Transcription Factors |
6 | Rituximab |
6 | Ribavirin |
6 | Reproduction |
6 | Protein Conformation |
6 | Prostatic Neoplasms, Castration-Resistant |
6 | Plants |
6 | Neoplasms, Glandular and Epithelial |
6 | Neoplasm Invasiveness |
6 | Mortality |
6 | Models, Molecular |
6 | Models, Genetic |
6 | Mendelian Randomization Analysis |
6 | MCF-7 Cells |
6 | International Agencies |
6 | Image Processing, Computer-Assisted |
6 | Hypertension |
6 | Huntington Disease |
6 | Hepacivirus |
6 | Geography |
6 | Genome, Plant |
6 | Genetic Markers |
6 | France |
6 | Forced Expiratory Volume |
6 | Epilepsy |
6 | Environment |
6 | Enhancer Elements, Genetic |
6 | Dementia |
6 | Cyclophosphamide |
6 | Cooperative Behavior |
6 | Colitis, Ulcerative |
6 | Cognition |
6 | Climate Change |
6 | Chemotherapy, Adjuvant |
6 | Bone Density Conservation Agents |
6 | Body Height |
6 | Bayes Theorem |
6 | BRCA2 Protein |
6 | Adrenal Cortex Hormones |
6 | Administration, Intravenous |
5 | World Health Organization |
5 | Uterine Cervical Neoplasms |
5 | Tuberculosis |
5 | Travel |
5 | Tissue Plasminogen Activator |
5 | Thrombectomy |
5 | Sulfonamides |
5 | Stents |
5 | Schizophrenia |
5 | Rheumatic Diseases |
5 | Regression Analysis |
5 | Quinazolines |
5 | Pulmonary Disease, Chronic Obstructive |
5 | Protein Binding |
5 | Prosthesis Design |
5 | Prednisone |
5 | Precision Medicine |
5 | Postoperative Complications |
5 | Population Surveillance |
5 | Patient Selection |
5 | Papillomavirus Infections |
5 | Pancreatic Neoplasms |
5 | Outcome and Process Assessment (Health Care) |
5 | Osteoarthritis, Knee |
5 | Oceans and Seas |
5 | Occupational Exposure |
5 | North America |
5 | Molecular Sequence Annotation |
5 | Mice, Knockout |
5 | Methotrexate |
5 | Mass Screening |
5 | Lupus Erythematosus, Systemic |
5 | Leukemia, Myeloid, Acute |
5 | Internet |
5 | Interferon-alpha |
5 | Infusions, Intravenous |
5 | Indoles |
5 | Hypoglycemic Agents |
5 | Hypertension, Pulmonary |
5 | Homozygote |
5 | Hepatitis B, Chronic |
5 | Heart Rate |
5 | Heart Failure |
5 | Health Services Accessibility |
5 | Health Knowledge, Attitudes, Practice |
5 | Graft vs Host Disease |
5 | Genotyping Techniques |
5 | Genome, Bacterial |
5 | Gene Dosage |
5 | Fishes |
5 | Exons |
5 | Exercise |
5 | Exercise Therapy |
5 | Epigenesis, Genetic |
5 | Endometrial Neoplasms |
5 | Educational Status |
5 | Early Detection of Cancer |
5 | Drug-Related Side Effects and Adverse Reactions |
5 | Drug Resistance, Neoplasm |
5 | Depressive Disorder, Major |
5 | Denosumab |
5 | Datasets as Topic |
5 | Dacarbazine |
5 | DNA, Viral |
5 | DNA Methylation |
5 | Coronary Artery Disease |
5 | Computer Simulation |
5 | Cluster Analysis |
5 | Climate |
5 | Cells, Cultured |
5 | Cell Cycle Proteins |
5 | Bacteria |
5 | Atrial Fibrillation |
5 | Anticholesteremic Agents |
5 | Administration, Oral |
5 | Acute Disease |
4 | Withholding Treatment |
4 | Vidarabine |
4 | Vaccination |
4 | Tumor Suppressor Protein p53 |
4 | Tumor Necrosis Factor-alpha |
4 | Triazoles |
4 | Transcriptome |
4 | Tidal Volume |
4 | Temperature |
4 | Telomere Homeostasis |
4 | Socioeconomic Factors |
4 | Sex Characteristics |
4 | Self Report |
4 | Salvage Therapy |
4 | Repressor Proteins |
4 | Renal Insufficiency, Chronic |
4 | Renal Dialysis |
4 | Reference Standards |
4 | Quality Control |
4 | Pyrroles |
4 | Psychometrics |
4 | Proteins |
4 | Prodromal Symptoms |
4 | Pregnancy Complications |
4 | Population Dynamics |
4 | Plant Leaves |
4 | Phylogeography |
4 | Peptides |
4 | Patient Outcome Assessment |
4 | Patient Care Planning |
4 | Papillomavirus Vaccines |
4 | Pain Management |
4 | Osteoarthritis |
4 | Organizational Objectives |
4 | Occupational Diseases |
4 | New Zealand |
4 | Myeloablative Agonists |
4 | MicroRNAs |
4 | Medulloblastoma |
4 | Medical Oncology |
4 | Malaria |
4 | Maintenance Chemotherapy |
4 | Lymphatic Metastasis |
4 | Linkage Disequilibrium |
4 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
4 | Leukemia, Lymphocytic, Chronic, B-Cell |
4 | Islands |
4 | Insulin |
4 | Insulin Resistance |
4 | Inflammation |
4 | In Situ Hybridization, Fluorescence |
4 | Image Interpretation, Computer-Assisted |
4 | Hyperlipoproteinemia Type II |
4 | History, Ancient |
4 | Hepatitis B Surface Antigens |
4 | Heart Defects, Congenital |
4 | HLA Antigens |
4 | HEK293 Cells |
4 | Germany |
4 | Genome |
4 | Genome, Viral |
4 | Gene Expression |
4 | Forests |
4 | Forecasting |
4 | Fibrinolytic Agents |
4 | Feeding and Eating Disorders |
4 | Drug Combinations |
4 | Doxorubicin |
4 | Disease Outbreaks |
4 | Diagnosis, Differential |
4 | Dermatitis, Atopic |
4 | Delphi Technique |
4 | DNA |
4 | DNA Repair |
4 | Cystic Fibrosis |
4 | Crohn Disease |
4 | Critical Illness |
4 | Critical Care |
4 | Coronary Angiography |
4 | Coral Reefs |
4 | Congresses as Topic |
4 | Cognitive Dysfunction |
4 | Clinical Trials, Phase III as Topic |
4 | Clinical Decision-Making |
4 | Chromosomes, Human, Pair 5 |
4 | Chromosomes, Human, Pair 2 |
4 | Chromosome Aberrations |
4 | Chromatin |
4 | Checklist |
4 | Cell Line |
4 | Carcinogenesis |
4 | Carboplatin |
4 | Breast Density |
4 | Bone and Bones |
4 | Bone Marrow Transplantation |
4 | Blood Transfusion |
4 | Bevacizumab |
4 | Apoptosis |
4 | Antirheumatic Agents |
4 | Antineoplastic Agents, Hormonal |
4 | Antineoplastic Agents, Alkylating |
4 | Anti-Bacterial Agents |
4 | Analysis of Variance |
4 | Alanine Transaminase |
4 | Adiposity |
4 | Adaptor Proteins, Signal Transducing |
4 | Abnormalities, Multiple |
3 | Waste Water |
3 | Waist-Hip Ratio |
3 | Waist Circumference |
3 | Virulence |
3 | Tropical Climate |
3 | Translational Medical Research |
3 | Tomography, Optical Coherence |
3 | Thrombolytic Therapy |
3 | Tenofovir |
3 | Stroke Volume |
3 | Stomach Neoplasms |
3 | Statistics as Topic |
3 | Sports |
3 | Soil |
3 | Soil Pollutants |
3 | Sjogren's Syndrome |
3 | Siblings |
3 | Sequence Homology, Amino Acid |
3 | Sequence Alignment |
3 | Selection, Genetic |
3 | Secondary Prevention |
3 | Seasons |
3 | Scleroderma, Diffuse |
3 | Rhinitis, Allergic |
3 | Review Literature as Topic |
3 | Research |
3 | Recombinant Fusion Proteins |
3 | Receptors, Cell Surface |
3 | Rats |
3 | Rare Diseases |
3 | Radiotherapy |
3 | Radiotherapy, Adjuvant |
3 | ROC Curve |
3 | RNA, Viral |
3 | Quinolones |
3 | Quality of Health Care |
3 | Quality Indicators, Health Care |
3 | Quality Improvement |
3 | Pyridines |
3 | Pyrazoles |
3 | Public Health Surveillance |
3 | Puberty |
3 | Proto-Oncogene Proteins |
3 | Propensity Score |
3 | Predatory Behavior |
3 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
3 | Positive-Pressure Respiration |
3 | Point Mutation |
3 | Plant Stems |
3 | Plant Proteins |
3 | Piperazines |
3 | Periodicals as Topic |
3 | Pediatrics |
3 | Patient-Centered Care |
3 | Patient Satisfaction |
3 | Patient Reported Outcome Measures |
3 | Patient Preference |
3 | Patient Participation |